These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10434435)

  • 1. [Acoustic distortion products otoacoustic emissions (DPOAE) in neonatal screening].
    Luppari R; Orzan E; Arslan E
    Acta Otorhinolaryngol Ital; 1999 Apr; 19(2):57-63. PubMed ID: 10434435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of auditory brainstem responses and otoacoustic emissions in hearing screening of high-risk neonates].
    Xu FL; Xing QJ; Cheng XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):460-3. PubMed ID: 18706161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of distortion product otoacoustic emissions and auditory brain-stem response in neonatal hearing screening, a comparative study].
    Xu ZM; Li J; Hu TZ; Sun JH; Shen XM
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(4):278-80. PubMed ID: 12812641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn hearing screening by transient evoked otoacoustic emissions: analysis of response as a function of risk factors.
    De Capua B; De Felice C; Costantini D; Bagnoli F; Passali D
    Acta Otorhinolaryngol Ital; 2003 Feb; 23(1):16-20. PubMed ID: 12812130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant hearing screening: effects of timeline.
    Tsui PW; McPherson B; Wong EC; Ng IH
    Clin Otolaryngol; 2008 Apr; 33(2):108-12. PubMed ID: 18429859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability of hearing screening in high-risk neonates: comparative study of otoacoustic emission, automated and conventional auditory brainstem response.
    Suppiej A; Rizzardi E; Zanardo V; Franzoi M; Ermani M; Orzan E
    Clin Neurophysiol; 2007 Apr; 118(4):869-76. PubMed ID: 17317296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Otoacoustic emissions. A futuristic objective hearing test].
    Plinkert PK
    Fortschr Med; 1993 Oct; 111(29):453-6. PubMed ID: 8258421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extremely low birth weight infants are at high risk for auditory neuropathy.
    Xoinis K; Weirather Y; Mavoori H; Shaha SH; Iwamoto LM
    J Perinatol; 2007 Nov; 27(11):718-23. PubMed ID: 17703185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The frequency of auditory neuropathy detected by universal newborn hearing screening program.
    Kirkim G; Serbetcioglu B; Erdag TK; Ceryan K
    Int J Pediatr Otorhinolaryngol; 2008 Oct; 72(10):1461-9. PubMed ID: 18674822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
    Mills DM
    Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial audiologic assessment of infants referred from well baby, special care, and neonatal intensive care unit nurseries.
    Karzon RK; Lieu JE
    Am J Audiol; 2006 Jun; 15(1):14-24. PubMed ID: 16803788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal neonatal hearing screening: the Siena (Italy) experience on 19,700 newborns.
    De Capua B; Costantini D; Martufi C; Latini G; Gentile M; De Felice C
    Early Hum Dev; 2007 Sep; 83(9):601-6. PubMed ID: 17307313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal hearing screening with transient evoked otoacoustic emissions in Western Saudi Arabia.
    Habib HS; Abdelgaffar H
    Int J Pediatr Otorhinolaryngol; 2005 Jun; 69(6):839-42. PubMed ID: 15885338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Audiologic evaluation of neonates with severe hyperbilirubinemia using transiently evoked otoacoustic emissions and auditory brainstem responses.
    Rhee CK; Park HM; Jang YJ
    Laryngoscope; 1999 Dec; 109(12):2005-8. PubMed ID: 10591364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Otoacoustic emissions for newborn hearing screening].
    Liao H; Wu Z; Zhou T
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Feb; 34(1):21-4. PubMed ID: 12764789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of high-risk infants using distortion product otoacoustic emissions.
    Bowes M; Smith C; Tan AK; Varette-Cerre P
    J Otolaryngol; 1999 Aug; 28(4):181-4. PubMed ID: 10461253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MB11 BERAphone and auditory brainstem response in newborns at audiologic risk: comparison of results.
    Melagrana A; Casale S; Calevo MG; Tarantino V
    Int J Pediatr Otorhinolaryngol; 2007 Aug; 71(8):1175-80. PubMed ID: 17532479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn hearing screening in Kuwait.
    Al-Kandari JM; Alshuaib WB
    Electromyogr Clin Neurophysiol; 2007 Sep; 47(6):305-13. PubMed ID: 17918507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of currently available devices designed for newborn hearing screening using automated auditory brainstem and/or otoacoustic emission measurements.
    Meier S; Narabayashi O; Probst R; Schmuziger N
    Int J Pediatr Otorhinolaryngol; 2004 Jul; 68(7):927-34. PubMed ID: 15183584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.